Equities

Blue Jet Healthcare Ltd

BLUEJET:NSI

Blue Jet Healthcare Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)534.00
  • Today's Change5.00 / 0.95%
  • Shares traded167.11k
  • 1 Year change+38.70%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 09:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in INRIncome statement in INRView more

Year on year Blue Jet Healthcare Ltd had no change in net income (1.64bn). Revenues were little changed (from 7.21bn to 7.12bn.) Year on year Blue Jet Healthcare Ltd had little change in net income (from 1.60bn to 1.64bn). Revenues were also little changed (from 7.21bn to 7.12bn.)
Gross margin55.65%
Net profit margin23.26%
Operating margin26.23%
Return on assets15.66%
Return on equity19.78%
Return on investment19.57%
More ▼

Cash flow in INRView more

In 2024, cash reserves at Blue Jet Healthcare Ltd fell by 244.84m. However, the company earned 2.41bn from its operations for a Cash Flow Margin of 33.90%. In addition the company used 2.64bn on investing activities and also paid 19.86m in financing cash flows.
Cash flow per share11.04
Price/Cash flow per share47.75
Book value per share53.27
Tangible book value per share53.26
More ▼

Balance sheet in INRView more

Blue Jet Healthcare Ltd uses little debt in its capital structure as supported by a debt to capital ratio of 0.12%.
Current ratio3.24
Quick ratio2.51
Total debt/total equity0.0012
Total debt/total capital0.0012
More ▼

Growth rates in INR

Year on year, growth in earnings per share excluding extraordinary items increased 2.33%.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)10.33%
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-6.86
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.